BMO Capital raised the firm’s price target on BrightSpring Health (BTSG) to $60 from $52 and keeps an Outperform rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTSG:
- BrightSpring Health reports Q1 adjusted EPS 39c, consensus 31c
- BrightSpring Health raises 2026 revenue view to $14.73B-$15.23B
- BrightSpring Health Services, Inc. (BTSG) Q1 Earnings Cheat Sheet
- William Blair healthcare IT analysts hold analyst/industry conference call
- Aveanna upgraded to Strong Buy from Outperform at Raymond James